These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effects of hypolipidemic drugs on bile acid metabolism in man. Miettinen TA Adv Lipid Res; 1981; 18():65-97. PubMed ID: 6275661 [No Abstract] [Full Text] [Related]
23. Diet and drug treatment of hyperlipidemia and atherosclerosis. Kuo PT Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101 [No Abstract] [Full Text] [Related]
24. [Xanthomatosis as a symptom of hyperlipidemic metabolic disorders. Relationship of the morphological picture to the lipid of three patients]. Rufli T; Stähelin H Dermatologica; 1972; 144(5):270-82. PubMed ID: 4351630 [No Abstract] [Full Text] [Related]
25. Effect of hypolipidemic drugs on serum lipoproteins. Carlson LA; Olsson AG Prog Biochem Pharmacol; 1979; 15():238-57. PubMed ID: 224397 [No Abstract] [Full Text] [Related]
26. Treatment of hypercholesterolemia. Grundy SM Am J Clin Nutr; 1977 Jun; 30(6):985-92. PubMed ID: 326023 [No Abstract] [Full Text] [Related]
27. [Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia]. Huth K; Blumenthal J; Schmahl FW Med Klin; 1973 Aug; 68(34):1089-97. PubMed ID: 4790868 [No Abstract] [Full Text] [Related]
28. Classification of hyperlipidaemias. Lewis B Proc R Soc Med; 1971 Sep; 64(9):905-8. PubMed ID: 5114287 [No Abstract] [Full Text] [Related]
29. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia. Orö L; Olsson AG; Rössner S; Carlson LA Postgrad Med J; 1975; 51(8):76-81. PubMed ID: 176639 [No Abstract] [Full Text] [Related]
30. Symposium on arteriosclerotic heart disease. Medical management of angina pectoris. Likoff W Geriatrics; 1972 May; 27(5):91-8. PubMed ID: 5022811 [No Abstract] [Full Text] [Related]
31. Bile acid metabolism in hyperlipoproteinaemia. Hellström K; Einarsson K Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796 [No Abstract] [Full Text] [Related]
32. [Present status of antilipemic agents]. Takekoshi N; Murakami E Nihon Rinsho; 1980 Sep; 38(9):3138-48. PubMed ID: 7019504 [No Abstract] [Full Text] [Related]
33. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia]. Carlson LA; Olsson AG; Orö L; Rössner S Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566 [No Abstract] [Full Text] [Related]
34. [Hiperlipidemia as a risk factor in coronary artery disease]. Michajlik A Wiad Lek; 1973 Mar; 26(6):529-34. PubMed ID: 4572266 [No Abstract] [Full Text] [Related]
35. [Treatment of hyperlipoproteinemia in relation to recent classifications]. Cloarec M Minerva Med; 1971 Sep; 62(72):3452-5. PubMed ID: 5097215 [No Abstract] [Full Text] [Related]
38. Corrective therapy of atherogenic hyperlipemia. de Gennes JL; Turpin G; Truffert J; Labrousse B Acta Cardiol; 1972; ():Suppl 15:115-3. PubMed ID: 4542781 [No Abstract] [Full Text] [Related]
39. Treatment of hyperlipidemia. Levy RI; Morganroth J; Rifkind BM N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888 [No Abstract] [Full Text] [Related]
40. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia. Orö L; Olsson AG; Rössner S; Carlson LA Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]